FIGENO is a
  FIGure
    GENerator
for GENOmics

With figeno, you can plot various types of sequencing data along genomic coordinates. Video overview: https://www.youtube.com/watch?v=h1cBeXoSYTA.

Address of the bookmark: https://github.com/CompEpigen/figeno

Address of the bookmark: https://github.com/soedinglab/MMseqs2

The Academy has an International Exchange Programme with Academies/Organizations in the countries: Brazil, China, France, Hungary, Iran, Israel, Nepal, Philippines, Poland, Scotland, Slovak Republic, Republic of Slovenia, Sudan and Taiwan.

Applications are invited from Indian Nationals for consideration by the Academy for the next calendar year.

• The applicant should be a scientist holding a regular (permanent) position in a recognized S & T Institution/University and actively engaged in research work in frontline areas.
• He/She should not have been abroad during the last 3 years under any INSA Programme.
• The scientist should have been accepted to work in an Institute/Laboratory in the country to be visited and this should be supported by a letter of invitation from the host abroad.
• Those who wish to visit abroad for three months should submit a detailed programme of their collaborative research work to be conducted.

All applications duly completed should be forwarded to the academy through proper channel by the employer/head of the Institute.

• Scientists selected for deputation abroad would be provided 100% travel support (by only Air India excursion class airfare, through shortest route from the place of duty in India to the nearest airport of host Institute and back) by INSA.
• Medical Insurance purchased in India.
• Visa fee (if any).
• The receiving Academy/Organization would provide local hospitality including internal travel abroad.

Contact for detail at 

www.insaindia.res.in

INDIAN NATIONAL SCIENCE ACADEMY
Bahadur Shah Zafar Marg, New Delhi – 110 002.
Telephone: 91-11-23221931 – 23221950 (EPABX),
Fax: 91-11- 23235648, 23231095

Research Area:
Linear models for microarray data
Digital gene expression technologies
Detection of molecular pathways
Bioinformatics resources for medical research

Link @ http://www.wehi.edu.au/faculty_members/professor_gordon_smyth/

The research covers diverse areas of evolutionary biology, and molecular evolution in particular. It combines theoretical and empirical approaches, and particularly evolutionary inference from genome sequence data.

Links @ http://www.gen.cam.ac.uk/research/welch/GroupPage/Home.html

For more information visit: http://www.snubi.org/TBC2013/

SciGenom Research Foundation (SGRF) and Institute of Genomics and Integrative Biology (IGIB) are pleased to host the Next-Generation Sequencing and Bioinformatics for Genomics & Healthcare conference.

In the ten years since the first human reference genome was completed for US$3 billion the sequencing technologies have radically changed leading to great reduction in sequencing cost. Today a human genome can be sequenced for under US$ 5000 in less than two weeks. It is expected that by the end of 2015 the cost of sequencing a human genome will drop to below thousand dollars. The next generation sequencing technologies over the past five years have enabled a large number of genomic studies that impact human health and disease. Also, this has made possible the growth of microbial, animal and plant genomics studies. While the data production has increased at a rapid pace challenges remain in analyzing and understanding the data. The conference will cover the next generation sequencing (NGS) technologies, bioinformatics for NGS and applications of NGS in many areas including personalized medicine.

For more info : http://www.scigenomconferences.com/2013/default.php

Biocon, India's largest publicly-held biotechnology firm, launched its second novel 'lab-to-market' molecule, Alzumab, to treat chronic plaque psoriasis at a cost 50 per cent lower than the existing one.

Biocon is bringing Alzumab (a biologic) in the form of a vial after working on it for nearly a decade. The work had initially started in a joint effort with the Center of Molecular Immunology, Havana, but Biocon took control of the programme soon after and also bought out its partner a few years ago. Biocon tell to the media that genotypic played a critical role in functional studies and clinical trial Genomics.

The Biocon drug, at around ₹ 7,500 a vial, will cost half as much as the currently available drugs - from Pfizer and J&J - to treat psoriasis, a skin disease that causes rough red areas where the skin comes off in small pieces. A patient is usually prescribed to consume more than 40 vials in a 24-week course.

17 Nov 2013 -22 Nov 2013

More at http://events.embo.org/13-large-scale-data/

Online Registration: https://www.conference-service.com/pc13-47/welcome.cgi